If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 161 - 170 of 269
Gut-oral-microbiota-brain Axis in Adults at Risk for AD
Objective
SCD Microbiome Project
Protocol No
NEURO-IIT-UMFLEET-SCDMICROB
A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Objective
Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Protocol No
NEURO-IMVT-1401-2401-CIDP
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson's Disease
Objective
Lenrispodun Adjunctive Therapy in Parkinsons Disease
Protocol No
NEURO-ITI-214-202-LENRISPODUN
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (TREAT-MS)
Objective
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (TREAT-MS)
Protocol No
NEURO-JH-TREAT-MS
Concept Representation in the Human Brain
Objective
Concept Representation in the Human Brain
Protocol No
NEURO-NIH-CONCEPT-REP-BRAIN
Anticoagulation in Intracerebral Hemorrhage Survivors for Stroke Prevention and Recovery
Objective
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
Protocol No
NEURO-NINDS-ASPIRE
Categories
Statin Use in Intracerebral Hemorrhage Patients
Objective
Statins In Intracerbral Hemorrhage (SATURN)
Protocol No
NEURO-NINDS-SATURN
Categories
A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study, Comparing the Efficacy and Safety of Remibrutinib 100mg B.I.D. Versus Teriflunomide 14mg Q.D. in Participants with Relapsing Multiple Sclerosis, Followed by Extended Treatment with Open-
Objective
Remibrutinib vs Teriflunomide in Relapsing MS
Protocol No
NEURO-NOVARTIS-LOU064
A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament
Objective
Current Therapy vs Transition to Ofatumumab After NfL Elevation (SOSTOS)
Protocol No
NEURO-NOVARTIS-SOSTOS
Parkinson's Foundation PD GENEration Genetic Registry
Objective
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE